
Oct. 30, 2023
Mental wellness continues to be a common, if uncomfortable, subject throughout the nation’s aviation community. In the first of a two-part series, experts share their perspectives about where the business aviation community stands on mental wellness matters, and what pilots might expect if they disclose a concern such as anxiety or depression to their aviation medical examiner. “In the past, it was very much not a thing that you wanted to talk about — mental health issues — when it came to the FAA,” notes aerospace medicine physician Dr. Greg Vanichkachorn. “What we have [now] seen with the FAA, with their language, as well as their policy changes, is that, indeed, they are starting to realize that pilots are human.”
In this episode of NBAA’s “Flight Plan,” host Rob Finfrock speaks with:
- Dr. Clayton Cowl, prior chair of the Division of Public Health, Infectious Disease and Occupational Medicine at Mayo Clinic, and a 20-year aviation medical examiner
- Mark Larsen, NBAA’s director of safety and flight operations
- Lee Rafalko, scheduling and finance manager for Corteva Agriscience and chair of the Fitness for Duty Working Group of the NBAA Safety Committee
- Dr. Greg Vanichkachorn, aerospace medicine physician and section chief for transportation medicine at Mayo Clinic
The NBAA Flight Plan podcast, which ran from 2009 to 2025, provided an overview of important developments affecting NBAA members, and the association’s work to advocate for their interest. The archive of past episodes will remain available for your enjoyment. Please note that no new episodes will be released.
Related Articles
March 3, 2026
NBAA IOC Day 2: Experts Focus on Mental Wellness in Bizav
Speaking at the 2026 Int’l Operators Conference, the federal air surgeon urged pilots to monitor their mental wellness and seek help sooner.
Read More
Jan/Feb 2026
NBAA Experts Explain Why the FAA Is Removing Some Barriers to Pilot Mental Health Treatment
You must to view this content.
Dec. 10, 2025
FAA Modifies Medical Certification Policies for Antidepressants, Insulin
The FAA has lowered wait times after an individual begins an antidepressant medication or changes, and now must wait only three months or a single, stable dose before completing required testing of the FAA antidepressant protocol.
Read More
Dec. 9, 2025
DOT Drug and Alcohol Testing Rates Remain at Minimum Levels, Reflecting Industry’s Good Compliance Record
The Department of Transportation released its 2026 testing rates for safety-sensitive positions covered by mandatory drug and alcohol testing programs, and the rates for 2026 remain unchanged from previous years.
Read More

International Business Aviation Council Ltd.